163 related articles for article (PubMed ID: 15221100)
21. The logical structure of the VIDEOFAR drug data base.
Caffari B; Raschetti R
Ann Ist Super Sanita; 1991; 27(2):195-200. PubMed ID: 1755570
[TBL] [Abstract][Full Text] [Related]
22. [Benefits of large healthcare databases for drug risk research].
Garbe E; Pigeot I
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
[TBL] [Abstract][Full Text] [Related]
23. Use of health care databases in pharmacoepidemiology.
Hennessy S
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
[TBL] [Abstract][Full Text] [Related]
24. VIDEOFAR: an epidemiologic tool for drug utilization studies.
Raschetti R
Ann Ist Super Sanita; 1991; 27(2):191-3. PubMed ID: 1755569
[TBL] [Abstract][Full Text] [Related]
25. Possible applications of drug prescription monitoring systems in Italy.
Bozzini L
Ann Ist Super Sanita; 1991; 27(2):207-11. PubMed ID: 1755572
[TBL] [Abstract][Full Text] [Related]
26. [Palliative care in the light of legal and regulatory requirements in Germany].
Cremer-Schaeffer P; Radbruch L
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Feb; 55(2):231-7. PubMed ID: 22290167
[TBL] [Abstract][Full Text] [Related]
27. [Is it possible to do pharmaco-epidemiological research using electronic databanks in the Swiss health care system?].
Meier ChR
Praxis (Bern 1994); 2003 May; 92(21):997-1000. PubMed ID: 12806695
[No Abstract] [Full Text] [Related]
28. [Data on palliative care in Germany : Which data sources are available and what do they tell?].
Prütz F; Saß AC
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jan; 60(1):26-36. PubMed ID: 27966014
[TBL] [Abstract][Full Text] [Related]
29. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
30. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
31. Health authorities and drug utilization studies.
Garcia Alonso F; Scott AI; Stika L; Westerholm B
WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843
[No Abstract] [Full Text] [Related]
32. [Ambulatory geriatric rehabilitation and its legal classification within the statutory health insurance system].
Plate A; Meinck M
Rehabilitation (Stuttg); 2005 Aug; 44(4):215-21. PubMed ID: 16059839
[TBL] [Abstract][Full Text] [Related]
33. [Integration of hospital social services in the rehabilitation of accident patients by the statutory accident insurance. Results of a one-year model project].
Lukasczik M; Geyer S; Neuderth S; Gerlich C; Weis I; Raiber I; Weber-Falkensammer H; Vogel H
Gesundheitswesen; 2008 Feb; 70(2):68-76. PubMed ID: 18348095
[TBL] [Abstract][Full Text] [Related]
34. [Work based on data of the Gmünder Ersatzkasse. An exemplary overview].
Grobe TG
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1106-17. PubMed ID: 18985404
[TBL] [Abstract][Full Text] [Related]
35. [Change in legal assessment of unconventional medical methods in federal health insurance--consequences for social medicine expert assessment].
Nüchtern E
Gesundheitswesen; 1998; 60(8-9):467-72. PubMed ID: 9816763
[TBL] [Abstract][Full Text] [Related]
36. [Evidence-based scientific analysis of fundamental Medical Services of Statutory Health Insurance internal principle assessment].
Mayer ED; Boukamp K; Kruse F; Hansis ML; Windeler J
Z Arztl Fortbild Qualitatssich; 2001 Feb; 95(2):113-9. PubMed ID: 11268876
[TBL] [Abstract][Full Text] [Related]
37. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.
Kimura T; Matsushita Y; Yang YH; Choi NK; Park BJ
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1237-45. PubMed ID: 21936017
[TBL] [Abstract][Full Text] [Related]
38. [Detection of drug risks after approval : Methods development for the use of routine statutory health insurance data].
Foraita R; Dijkstra L; Falkenberg F; Garling M; Linder R; Pflock R; Rizkallah MR; Schwaninger M; Wright MN; Pigeot I
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1075-1081. PubMed ID: 30027343
[TBL] [Abstract][Full Text] [Related]
39. [Sample survey of persons insured in statutory health insurance institutions in Hessen--concept and realisation of person-related data base].
Ihle P; Köster I; Herholz H; Rambow-Bertram P; Schardt T; Schubert I
Gesundheitswesen; 2005; 67(8-9):638-45. PubMed ID: 16217718
[TBL] [Abstract][Full Text] [Related]
40. [Databases as a source for monitoring systems of drug safety].
Pigeot I; Ahrens W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):513-7. PubMed ID: 15221098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
